COVID-19 and Respiratory Comorbidities: ARDS & ILD

Released On
March 2, 2021

Expires On
March 2, 2022

Media Type
Internet

Completion Time
60 minutes

Specialty
Acute Care, Critical Care, Education, Hospitalist, Infectious Disease, Other, Pulmonology

Topic(s)
Asthma, Pulmonary Fibrosis, Rehabilitation, Respiratory

Scroll to the Bottom of this Information to Begin this Course

This activity is provided by The France Foundation.

This activity is supported by an educational grant from Boehringer Ingelheim Pharmaceuticals, Inc.

Credit Available

  • Physicians — maximum of 1.0 AMA PRA Category 1 Credit(s)
  • Nurses — 1.0 Contact Hours
  • Pharmacists — 1.0 CEU
  • Respiratory Therapists — 1.0 hours CRCE

All other health care professionals completing this course will be issued a statement of participation.

Target Audience

This activity is designed to meet the educational needs of pulmonologists, respiratory therapists, pharmacists, primary care providers, and other health care providers involved in the care of patients with and recovering from COVID-19.

Program Overview

This activity will cover COVID-19 and respiratory comorbidities such as acute respiratory distress syndrome and interstital lung disease.

Learning Objectives

Upon completion of this activity, participants should be better able to:

  • Describe COVID-19 induced acute lung injury and ARDS
  • Discuss the potential progression of COVID-19 effects on the lungs
  • Review long-term management strategies for these patients
  • Discuss emerging clinical information regarding COVID-19 and chronic lung disease such as ILD

Faculty

FACULTY_NAME

Christopher King, MD, FACP, FCCP

Inova Fairfax Hospital
Falls Church, VA
Assistant Clinical Professor of Medicine
Virginia Commonwealth University
Richmond, VA

FACULTY_NAME

Shambhu Aryal, MD

Inova Fairfax Hospital
Falls Church, VA

FACULTY_NAME

Vikramjit S. Khangoora, MD

Internal Medicine Specialist
Inova Fairfax Hospital
Falls Church, VA

FACULTY_NAME

Erin Reynolds, BSN, RN, CCRN, CNML

Clinical Director of Medical Surgical Intensive Care Unit
Inova Fairfax Hospital
Falls Church, VA

Accreditation/Approval Statement

The France Foundation is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

This nursing continuing professional development activity was approved by Montana Nurses Association, an accredited approver with distinction by the American Nurses Credentialing Center's Commission on Accreditation. Date of approval: 03/15/2021; Expiration Date: 01/29/2022

Credit Designation

Physicians

The France Foundation designates this enduring activity for a maximum of 1.0 AMA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the enduring activity.

Nurses

This nursing continuing professional development activity was approved by Montana Nurses Association, an accredited approver with distinction by the American Nurses Credentialing Center's Commission on Accreditation.

Nursing CE launch date: March 15, 2021
Nursing CE expiration date: January 29, 2022

Respiratory Therapists

This program has been approved for 1.0 contact hours Continuing Respiratory Care Education (CRCE) credit by the American Association for Respiratory Care, 9425, N. MacArthur Blvd, Suite 100, Irving TX 75063.

Pharmacists

The France Foundation is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education and will award 1.0 CEU to pharmacists who complete the activity and evaluation forms. There is no fee to participate in this activity. This is a knowledge-based educational activity. Your CE credits will be submitted electronically to the CPE Monitor. CE providers must upload participant information within 60 days from the date the participant completed the live activity. Please submit all evaluations and credit requests no later than 30 days after this live activity to ensure your credit fulfillment, as CE credit cannot be awarded past 60 days from the activity date.

ACPE No. 0391-0000-21-021-H01-P.

Disclosures of Conflicts of Interest

The faculty listed below report that they have no relevant financial relationships to disclose:

  • Shambhu Aryal, MD
  • Vikramjit S. Khangoora, MD
  • Erin Reynolds, BSN, RN, CCRN, CNML

The following faculty report that they have relevant financial relationships to disclose:

  • Christopher King, MD, FACP, FCCP, reports that he has done consulting for Actelion, Boehringer Ingelheim Pharmaceuticals, Inc, and United Therapeutics.

Instructions for Participation and Credit

There are no fees for participating and receiving CME credit for this enduring activity. To receive CME credit participants must:

  1. Read the CME/CE information and faculty disclosures.
  2. Participate in the online activity.
  3. Submit the evaluation form.

If you are requesting AMA PRA Category 1 Credit™, nursing credit, respiratory therapy credit, or a certificate of participation—your CME/CE certificate will be emailed to you.

If you are requesting ACPE pharmacy credit—your CE credits will be submitted electronically to the CPE Monitor.

Course Viewing Requirements

Supported Browsers:
Internet Explorer 8.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1 and above
Google Chrome 28.0+ for Windows, Mac OS, or Linux
Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
Safari 6.0+ for Mac OSX 10.7 and above

Supported Phones & Tablets:
Android 4.0.3 and above
iPhone/iPad with iOS 6.1 or above

Disclosure of Unlabeled Use

The France Foundation (TFF) requires CME faculty (speakers) to disclose when products or procedures being discussed are off label, unlabeled, experimental, and/or investigational, and any limitations on the information that is presented, such as data that are preliminary, or that represent ongoing research, interim analyses, and/or unsupported opinion. Faculty in this activity may discuss information about pharmaceutical agents that is outside of US Food and Drug Administration approved labeling. This information is intended solely for continuing medical education and is not intended to promote off-label use of these medications. TFF does not recommend the use of any agent outside of the labeled indications. If you have questions, contact the Medical Affairs Department of the manufacturer for the most recent prescribing information.

Disclaimer

The France Foundation presents this information for educational purposes only. The content is provided solely by faculty who have been selected because of recognized expertise in their field. Participants have the professional responsibility to ensure that products are prescribed and used appropriately on the basis of their own clinical judgment and accepted standards of care. The France Foundation and the commercial supporter(s) assume no liability for the information herein.

Contact Information

For CME questions please contact: info@francefoundation.com.